Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,148,647
-$1,086,331 QoQ
Shares Held
338,399
+2.9% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#462
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Norinchukin Bank, The holds $196,729,984 across 9 Drug Manufacturers - General names. PFE ranks #7 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
48,255 | $57,878,499 | |
| 2 | JNJ |
Johnson & Johnson
|
150,334 | $38,180,325 | |
| 3 | ABBV |
AbbVie Inc.
|
107,762 | $27,117,229 | |
| 4 | AMGN |
Amgen Inc
|
59,210 | $21,441,125 | |
| 5 | MRK |
Merck & Co., Inc.
|
152,112 | $19,546,392 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
120,669 | $15,245,321 | |
| 7 | PFE |
Pfizer Inc
This page
|
338,399 | $8,148,647 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
124,541 | $7,176,052 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,148,647 | 338,399 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $9,234,978 | 328,881 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $8,169,465 | 328,091 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,888,862 | 309,610 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $7,300,869 | 301,191 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $7,426,292 | 293,066 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $6,749,152 | 254,397 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $6,746,319 | 233,114 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,608,926 | 200,462 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,456,149 | 196,618 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $5,738,825 | 199,334 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $7,307,914 | 220,317 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $17,661,420 | 481,500 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $13,560,532 | 332,366 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $16,469,919 | 321,427 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $16,630,287 | 380,034 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $18,166,680 | 346,494 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $26,605,741 | 513,922 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $28,372,757 | 480,487 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $20,774,561 | 483,017 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $18,137,893 | 463,174 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $16,808,328 | 463,934 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $16,745,384 | 454,914 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $17,196,648 | 468,574 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $15,942,018 | 487,523 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $16,564,647 | 507,496 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||